2,4-Diaminobutyric acid
![]() | |
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name
2,4-Diaminobutanoic acid | |
| Other names
α,γ-diaminobutanoic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.005.607 |
| EC Number |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C4H10N2O2 | |
| Molar mass | 118.136 g·mol−1 |
| Pharmacology | |
| Drug class | GABA-T inhibitor; GABA reuptake inhibitor |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
2,4-Diaminobutyric acid, also known as DABA, is GABA-T non-competitive inhibitor and a GABA reuptake inhibitor. In many bacteria, its (S) enantiomer is a natural product which is an intermediate to the osmoprotectant, ectoine.
Mechanism of action
DABA's main action is being an inhibitor of GABA transaminase, an enzyme that converts GABA back to glutamate. When the enzyme is inhibited, this conversion cannot happen, therefore, GABA levels are elevated.[1]
It has also been observed that 2,4-diaminobutyric acid is a GABA reuptake inhibitor.[2] This action further elevates levels of GABA.
Toxicity
In addition to being a neurotoxin, DABA can also cause liver damage.
Its potential as an anticonvulsant is unclear, it has been shown to have anticonvulsant properties against picrotoxin, but over the long term, it could paradoxically cause convulsions.[2][3]
Biosynthesis and metabolism
The (S) enantiomer of DABA is a natural product which is an intermediate in many bacteria to the osmoprotectant, ectoine. It is produced by the enzyme diaminobutyrate-2-oxoglutarate transaminase that produces it from L-aspartic-4-semialdehyde and glutamic acid.[4] It has been found in Halomonas elongata and Bacillus pasteurii.[5][6]
In other organisms including Acinetobacter baumannii and Haemophilus influenzae, DABA is the precursor to 1,3-diaminopropane.[7][8]
References
- ↑ Beart PM, Bilal K (July 1977). "l-2,4-Diaminobutyric acid and the GABA system". Neuroscience Letters. 5 (3–4): 193–198. doi:10.1016/0304-3940(77)90046-5. PMID 19604993. S2CID 34289803.
- 1 2 Taberner PV, Pycock CJ (1981). "The Effects of GABA Uptake Inhibitors including 2, 4-Diaminobutyric Acid on GABA Metabolism in vivo". In Pycock CJ, Taberner PV (eds.). Central Neurotransmitter Turnover. pp. 177–182. doi:10.1007/978-1-4615-9778-0_12. ISBN 978-1-4615-9780-3.
- ↑ O'Neal RM, Chen CH, Reynolds CS, Meghal SK, Koeppe RE (February 1968). "The 'neurotoxicity' of L-2,4-diaminobutyric acid". The Biochemical Journal. 106 (3): 699–706. doi:10.1042/bj1060699. PMC 1198561. PMID 5639925.
- ↑ Peters P, Galinski EA, Truper HG (1990). "The biosynthesis of ectoine". FEMS Microbiol. Lett. 71 (1–2): 157–162. doi:10.1111/j.1574-6968.1990.tb03815.x.
- ↑ Ono H, Sawada K, Khunajakr N, et al. (1999). "Characterization of biosynthetic enzymes for ectoine as a compatible solute in a moderately halophilic eubacterium, Halomonas elongata". J. Bacteriol. 181 (1): 91–9. doi:10.1128/JB.181.1.91-99.1999. PMC 103536. PMID 9864317.
- ↑ Kuhlmann AU, Bremer E (2002). "Osmotically regulated synthesis of the compatible solute ectoine in Bacillus pasteurii and related Bacillus spp". Appl. Environ. Microbiol. 68 (2): 772–83. Bibcode:2002ApEnM..68..772K. doi:10.1128/AEM.68.2.772-783.2002. PMC 126723. PMID 11823218.
- ↑ Ikai H, Yamamoto S (1997). "Identification and analysis of a gene encoding L-2,4-diaminobutyrate:2-ketoglutarate 4-aminotransferase involved in the 1,3-diaminopropane production pathway in Acinetobacter baumannii". J. Bacteriol. 179 (16): 5118–25. doi:10.1128/jb.179.16.5118-5125.1997. PMC 179370. PMID 9260954.
- ↑ Ikai H, Yamamoto S (1998). "Two genes involved in the 1,3-diaminopropane production pathway in Haemophilus influenzae". Biol. Pharm. Bull. 21 (2): 170–3. doi:10.1248/bpb.21.170. PMID 9514614.


-2-Amino-4-oxobutanoic_acid.svg.png)

-2%252C4-Diaminobutyric_acid.svg.png)
